Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |